SCHEMBL5378305

SCHEMBL5378305

Cc1ncc(N2CCC(O)C2)n1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 3/20 0.40
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE10A Q9Y233 2/20 0.37
NOTUM Q6P988 1/20 0.36
MYC P01106 2/20 0.36
WDR5 P61964 2/20 0.36
CDK4 P11802 2/20 0.35
CDK6 Q00534 2/20 0.35
ABL1 P00519 1/20 0.35
CNR2 P34972 1/20 0.35
RORC P51449 3/20 0.34
IRAK1 P51617 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
SLC2A1 P11166 1/20 0.34
SLC2A3 P11169 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5374769 0.85 AURKA (0.40) AVPR1AMAPTALDH1A1NPC1RAB9A
SCHEMBL5365800 0.78 NPC1 (0.42) AVPR1AMAPTALDH1A1NPC1RAB9A
SCHEMBL5373081 0.77 PDE10A (0.37) MAPTPDE10AABL1CNR2IRAK1
SCHEMBL5365790 0.77 GAA (0.44) AVPR1AMAPTALDH1A1NPC1RAB9A
SCHEMBL5374140 0.76 PTPN11 (0.38) AVPR1APDE10ANOTUMMYCWDR5
SCHEMBL5383817 0.76 IRAK4 (0.41) MAPTALDH1A1PDE10AABL1CNR2
SCHEMBL5365916 0.75 NOTUM (0.38) MAPTALDH1A1NPC1RAB9AHPGD
SCHEMBL17392707 0.74 NOTUM (0.59) ALDH1A1NOTUMRORC
SCHEMBL3436548 0.74 NOTUM (0.59) ALDH1A1NOTUMRORC
SCHEMBL6398487 0.74 NOTUM (0.59) ALDH1A1NOTUMRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 AVPR1A 4360/4885MAPT 588/4885ALDH1A1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.